Forbes MediClinic provides physician-administered IV ketamine therapy for adults with treatment-resistant depression or PTSD—rapid, evidence-based relief in a purpose-built setting.
One fax starts the process; we handle dosing, monitoring, and follow-up while you remain the patient’s primary mental-health care provider.
• Rapid relief for TRD & PTSD. Ketamine can lift mood within hours or days when standard regimens have failed.
• Physician-led safety. All infusions are administered and monitored by an anesthesiologist, Dr Stewart Forbes, in a purpose-built facility.
• Streamlined process. Direct-fax referral, clear inclusion/exclusion criteria, and prompt feedback to the referring provider.
Inclusion (patient must meet all):
• Age 18 years or older
• Documented and diagnosed treatment-resistant depression* and/or PTSD
• Capacity to provide informed consent
• Cleared by our anesthesiologist after a medical questionnaire & review
*Treatment-Resistant Depression = failure of 2 or more trials of guideline-concordant antidepressants.
• Rapid relief. Many patients feel meaningful improvement within hours – not weeks – after an infusion.
• Robust clinical evidence. 20 + years of peer‑reviewed trials confirm ketamine’s antidepressant and anti‑anxiety effects, even in treatment‑resistant cases.
• Unique mechanism. Ketamine targets NMDA receptors and sparks neuro‑plastic changes that conventional antidepressants cannot match.
• Physician‑led safety. All infusions are administered by a licensed and certified anesthesiologist in a fully monitored setting.
• Berman 2000 First human proof-of-concept: mood lift < 4 h
PubMed 10686270
• Zarate 2006 RCT: significant response in TRD
PubMed 16894061
• Murrough 2013 Two-site RCT: robust effect through day 7
PubMed 23982301
• Feder 2014 RCT: symptom drop in chronic PTSD
PubMed 24740528
